At the heart of the HCB is its team of dedicated professionals, including technical, administrative and research personnel who ensure the delivery of quality specimens for research. Visit our team page to learn more about their roles and skills.
The HCB operates to the highest ethical standards with a focus on excellence in research governance. All biobanking activities are conducted with Ethical approval from the Hunter New England Human Research Ethics Committee to ensure all procedures are in line with best practice standards.
The HCB is governed by a Management Committee which includes member who represent the research and pathology interests of local cancer researchers. The aim of the HCB management committee is to ensure the development and ongoing function of a comprehensive, validate, well annotated cancer biobank to provide cancer researchers with fast, easy access to high quality patient samples – linked to clinical outcomes. The Management committee reports to the Hunter Cancer Research Alliance (HCRA) Director and Executive Committee.
The HCB is a major research platform provided by the Hunter Cancer Research Alliance.
HMRI provides lab space and location for the HCB.
The University provides support for staff and management of the HCB.
The Calvary Mater Newcastle provides a collection site for biospecimens that are housed within the HCB.
The HCB would not be able to obtain research biospecimens without the support of the HNE local health disctrict.
Pathology North is a major collaborator with the HCB in providing access to tissue samples collected when patients have surgery.
The Cancer Institute of NSW provides financial support for biobanking initiatives in cancer research.
The Mark Hughes Foundation provides generous support for the Brain Cancer Biobank initiative in the HCB.
The HCB has been established through the Hunter Cancer Research Alliance and works in partnerships with the Hunter Medical Research Institute and University of Newcastle who provide the biobank with space and facilities. Pathology North is integral to acquisition of biospecimens while working with the Calvary Mater Newcastle and Hunter New England Health provides the biobank access to collaborating clinicians and patients willing to donate specimens.
Funding is essential for the successful establishment and running of the HCB. We acknowledge the support received through the Cancer Institute of NSW in supporting the HCB through HCRA. The Mark Hughes Foundation generously supports the brain cancer biobank as a special collection of the HCB.